New research out of the journal Health Psychology.

They may do more harm than good.

It's not a one-size-fits-all drug.

Sticking to the same meals and eating a consistent number of calories each day may help people lose more weight, according to ...

Experts break down the latest findings.

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs ...

Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...

In a 12-week randomized trial, replacing refined wheat with wholegrain rye in a calorie-restricted diet did not produce ...

MASLD, affecting 30% of adults, is driven by obesity and insulin resistance, leading to severe liver conditions if untreated. GLP-1 RAs, such as liraglutide and semaglutide, show strong evidence for ...

Patients who discontinue popular weight-loss medications like Ozempic and Wegovy typically regain the weight they lost within two years, according to new research published in the British Medical ...

Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.